In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Magali Dumont Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Magali
Last Name:Dumont
Title:Assistant Professor in Neuroscience
Advanced Degrees:Ph.D.
Affiliation:Weill Cornell Medical College
Department:Neurology and Neuroscience
Street Address 1:1300 York Avenue
Street Address 2:Room A578
City:NY
State/Province:NY
Zip/Postal Code:10065
Country/Territory:U.S.A.
Phone:212 746 4818
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 15 August 2010]
View all comments by Magali Dumont
Clinical Interests:
Aging Process, Alzheimer Disease
Research Focus:
Oxidative Stress, Animal Models, A-beta PP/A-beta, Neurobiology
Work Sector(s):
Medical hospital
Top Papers
1.Lalonde R., Dumont M., Staufenbiel M., Sturchler-Pierrat C. & Strazielle C. (2002). Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res. 956, 36-44
2.Lalonde R., Dumont M., Fukuchi K. & Strazielle C. (2002). Transgenic mice expressing the human C99 terminal fragment of beta-APP: Effects on spatial learning, exploration, anxiety, and motor coordination. Exp. Gerontol. 37,1399-1410
3.Dumont M., Strazielle C., Staufenbiel M. & Lalonde R. (2004). Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation. Brain Res. 1024, 113-121
4.Dumont M., Lalonde R., Ghersi-Egea J.-F., Fukuchi K. & Strazielle C. (2006). Regional acetylcholinesterase activity and its correlation with behavioral performances in transgenic mice expressing the human C99 fragment of APP. J. Neural Transm. 113, 1225-1241
Neuroscience 153, 986-996
5.Dumont M., Wille E., Calingasan N.Y., Tampellini D., Williams C., Gouras G.K., Liby K., Sporn M., Beal M.F. & Lin M.T. (2009). Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease. J. Neurochem. 109, 502-512
6.Dumont M., Wille E., Stack C., Calingasan N., Beal M.F. & Lin M.T. (2009). Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer’s disease. FASEB J. 23, 2459-2466
7.Tampellini D., Rahman N., Gallo E., Huang Z., Dumont M., Capetillo-Zarate E., Ma T., Zheng R., Lu B., Nanus D., Lin M. & Gouras, G.K. (2009). Synaptic activity reduces intraneuronal A-beta, promotes APP transport to synapses and protects against A-beta-related synaptic alterations. J. Neurosci. 29, 9704-9713
8.Dumont M.*, Ho D., Calingasan N.Y., Xu H., Gibson G. & Beal M.F. (2009). Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in transgenic Alzheimer mice. Free Rad. Biol. Med. 47, 1019-1027
9.Dumont M., Wille E., Calingasan N.Y., Nathan C., Beal M.F. & Lin M.T. (2009). N-Iminoethyl-L-Lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition. Neurochemistry Int. 56, 345-351
10.Stack C., Ho D., Wille E., Calingasan N.Y., Williams C., Liby K., Sporn M., Dumont M.* & Beal M.F. (2010). Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington’s disease. Free Rad. Biol. Med. (in press)

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad